administrative supplements for development of risk
play

Administrative Supplements for Development of Risk-Stratified Cancer Survivorship Care Algorithms NOT-CA-20-038 Division of Cancer Control and Population Sciences April 7, 2020 Using WebEx and Webinar Training Logistics All lines will be

0 downloads 5 Views 293 KB Size Report
  1. Administrative Supplements for Development of Risk-Stratified Cancer Survivorship Care Algorithms NOT-CA-20-038 Division of Cancer Control and Population Sciences April 7, 2020

  2. Using WebEx and Webinar Training Logistics ▪ All lines will be in listen-only mode ▪ Submit questions at any time during the presentation. Type into the Q&A Panel and select Host ▪ A moderator will ask the question on your behalf during the Q&A portions of the training ▪ This training webinar is being recorded and will be posted at a later date 2

  3. Webinar presenters Michelle Mollica, PhD, Lisa Gallicchio, PhD MPH, RN, OCN Program Director, Program Director, Epidemiology and Healthcare Delivery Genomics Research Research Program Program 3

  4. 1. Background 2. Supplement notice details 3. Questions ▪ Note: questions about specific projects will not be addressed ▪ Note: questions about COVID-19 supplements will not be addressed. Please see: https://grants.nih.gov/policy/natural- disasters/corona-virus.htm 4

  5. Background 5

  6. Cancer Survivors: Estimated prevalence from 1975 to 2040 by age (in millions) 30 2040, 26.1M 25 20 2016, Millions 85+ 15.5 M 15 75-84 65-74 10 50-64 1975, < 50 3.6 M 5 0 1975 1980 1985 1990 1995 2000 2005 2010 2015 2020 2025 2030 2035 2040 Source: Bluethmann, Mariotto & Rowland, CEBP 2016

  7. Survivorship Care After Active Treatment Surveillance/ Prevention/ Health management of surveillance of promotion/ effects of cancer recurrence and preventive care and its new cancers treatment 7 Institute of Medicine. From cancer patient to cancer survivor: Lost in transition. Washington, DC: Institute of Medicine; 2005.

  8. Risk-stratified Survivorship Care ▪ Follow-up care pathways for survivors tailored based on risk for specific factors, including symptom burden, recurrence, subsequent malignancies, functional impairments Shorter-term transition Low Risk to non-oncology providers Intermediate transition Moderate to non-oncology Risk providers Long-term follow-up High Risk led mostly by oncology specialists 8

  9. Supplement Notice Details 9

  10. Administrative Supplements for Development of Risk- Stratified Cancer Survivorship Care Algorithms ▪ Goal: to stimulate research focused on the development and/or validation of risk-stratification algorithms that categorize survivors into meaningful risk-stratified groups to inform appropriate follow-up care ▪ NCI is seeking supplement applications that propose methodological approaches to identify individuals within each group NOT-CA-20-038 Receipt date: May 15, 2020 10

  11. Eligibility ▪ Administrative supplement applications are limited to current NCI- funded projects ▪ Applicants must hold an active eligible grant (R01, U01, R37, P01, U19, UM1) ▪ Supplements must support work within the scope of the parent award ▪ Can confirm this with your Program Director ▪ Please see NOT-CA-20-038 for details on application process 11

  12. Important Considerations ▪ Applicants should utilize existing parent study data alone or in conjunction with data from other sources (e.g., electronic medical records, cancer registry, and/or claims data) ▪ Supplement is focused on adult cancer survivors, including adult survivors of childhood cancers ▪ Applicants may propose a single or multiple cancer types ▪ If focusing on one cancer type, application should address how this approach may serve as prototype for other cancers 12

  13. Budget ▪ Budgets should not exceed more than $150,000 in total costs ▪ Supplement project must be within the currently approved project period for the existing parent award ▪ Requests for no-cost extensions to accommodate a supplement will not be permitted 13

  14. Review process ▪ NCI will conduct reviews of submitted applications and will consider: ▪ Scientific merit of the proposed study ▪ Innovation of the proposed study ▪ Potential of the project to develop and/or validate a risk stratified algorithm ▪ Potential of developed algorithm to be utilized to inform care pathways for survivorship care 14

  15. Tips for Applicants ▪ Review NOT-CA-20-038 carefully for instructions ▪ Application Due Date: May 15, 2020 ▪ Webinar and FAQ will be posted on our website: https://healthcaredelivery.cancer.gov/media ▪ Connect with us early Michelle Mollica, PhD, MPH, RN, OCN Email: michelle.mollica@nih.gov Lisa Gallicchio, PhD Email: Lisa.gallicchio@nih.gov 15

  16. Questions? Please type your questions in the Q & A section on WebEx Stay connected with us! Subscribe to our email listserv using the link on our homepage: healthcaredelivery.cancer.gov epi.grants.cancer.gov Follow us on Twitter: @NCICareDelivRes and @NCIEpi 16

  17. www.cancer.gov www.cancer.gov/espanol

Recommend Documents


the effect of zinc and or multivitamin
The effect of zinc and/or multivitamin

1 The effect of zinc and/or multivitamin supplements on Early Childhood

adequate diet supplements
Adequate Diet > Supplements Kyle

Adequate Diet > Supplements Kyle Draves Professor Viggiano Public

office of the state auditor
OFFICE OF THE STATE AUDITOR

OFFICE OF THE STATE AUDITOR Administrative Support of Charter Schools: OSA

and training services
and training services. Builds and

Regional organisation that assists member countries to achieve their

s p
S P PORT RODUCTS supplements that

S PORT NUTRITION AND SPORT SUPPLEMENTS E NG .A HMAD SHYYAB J ORDAN F OOD &

botanical food supplements towards a workable regulatory
BOTANICAL FOOD SUPPLEMENTS: TOWARDS A

BOTANICAL FOOD SUPPLEMENTS: TOWARDS A WOR...

kitsap county
KITSAP COUNTY DEPARTMENT OF

KITSAP COUNTY DEPARTMENT OF ADMINISTRATIVE SERVICES DEPARTMENT OF

what is administrative law
What is Administrative Law?

A DMINISTRATIVE L AW FOR L EGISLATORS MICHAEL P. MANION Deputy Director

dietary supplements for health amp wellness from a to zinc
DIETARY SUPPLEMENTS FOR HEALTH &

DIETARY SUPPLEMENTS FOR HEALTH & WELLNESS FROM A TO ZINC Cory Davidson

administrative panel administrative panel
ADMINISTRATIVE PANEL ADMINISTRATIVE

ADMINISTRATIVE PANEL ADMINISTRATIVE PANEL Administrative panel is an

methodologies for vaccine safety surveillance nick
Methodologies for vaccine safety

Methodologies for vaccine safety surveillance Nick Andrews, Statistics Unit

network surveillance netsurveyorweb
Network Surveillance NetSurveyorWeb

Network Surveillance NetSurveyorWeb 818 West Diamond Avenue - Third Floor,

resolving the psa testing controversy
Resolving the PSA testing controversy

Resolving the PSA testing controversy Professor Villis Marshall AC Professor

an overview of the crisis coag grant activities
An Overview of the Crisis CoAg Grant

An Overview of the Crisis CoAg Grant Activities Prepared for ELC Flu

of enforcement under the ccpsa
of Enforcement Under the CCPSA

Chemicals Management Plan: An Overview of Enforcement Under the CCPSA

centers for medicare amp
Centers for Medicare & Medicaid

Centers for Medicare & Medicaid Services Inpatient Rehabilitation

im proving outcom es for m en with prostate cancer
Im proving outcom es for m en with

Im proving outcom es for m en with prostate cancer Prostate Cancer Awareness

what is an hpv ambassador
What is an HPV Ambassador? A

Ask Me About HPVI Flovida DepavtllV\eVtt of Hea(t1'l What is an HPV

s o c i a l m e d i a i n v e s t i g a t i o n s
S O C I A L M E D I A I N V E S T I G A

S O C I A L M E D I A I N V E S T I G A T I O N S : D O N T M I S S T H E B O

managing diabetes and hyperglycemia safely in the complex
Managing Diabetes and Hyperglycemia

Managing Diabetes and Hyperglycemia Safely in the Complex Hospital Setting

zika vir us and oklahoma vulne r able populations
Zika Vir us and Oklahoma Vulne r

Zika Vir us and Oklahoma Vulne r able Populations Ja n F ig a rt, DHA, RN

influence of gene expression on progression of renal cell
Influence of Gene Expression on

Influence of Gene Expression on progression of Renal Cell Carcinoma Jong Y.